Copyright
©The Author(s) 2025.
World J Clin Oncol. Aug 24, 2025; 16(8): 107596
Published online Aug 24, 2025. doi: 10.5306/wjco.v16.i8.107596
Published online Aug 24, 2025. doi: 10.5306/wjco.v16.i8.107596
Table 2 Various biomarkers predicting outcomes after sphincter preservation surgery[77]
Classification | Markers |
Haematological markers[78] | Neutrophil–lymphocyte ratio, preoperative plasma fibrinogen and neutrophil–lymphocyte ratio, platelet-to-lymphocyte ratio, monocytes–lymphocyte ratio |
Inflammatory markers[78] | Systemic immune-inflammation index, prognostic nutritional index, systemic inflammation response index, ∆pan-immune-inflammation value, CD8+ cell population, interleukin-6 population, TNF-alpha, CRP level |
Molecular markers | MSI, BRAF, KRAS, EGFR status, PI3K AKT pathway, CEA level |
Liquid biopsy | Circulating tumor cells, circulating tumor DNA, microRNA, cell-free DNA |
Pathologic | Tumor budding, EMVI on MRI |
- Citation: Sarangi Y, Kumar A. Predictive model for sphincter preservation in lower rectal cancer. World J Clin Oncol 2025; 16(8): 107596
- URL: https://www.wjgnet.com/2218-4333/full/v16/i8/107596.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i8.107596